153 related articles for article (PubMed ID: 3481339)
1. [Experiences with the tumor markers Ca 125 and plasma ribonuclease in ovarian cancer].
Lücke R; Benz R; Kraus H
Geburtshilfe Frauenheilkd; 1987 Dec; 47(12):846-9. PubMed ID: 3481339
[TBL] [Abstract][Full Text] [Related]
2. [Serum CA 125 values and histologic findings at the time of second-look laparotomy in ovarian cancer].
Meier W; Stieber P; Fateh-Moghadam A; Eiermann W; Hepp H
Geburtshilfe Frauenheilkd; 1988 May; 48(5):331-3. PubMed ID: 3165078
[TBL] [Abstract][Full Text] [Related]
3. [Diagnosis of the recurrence of epithelial ovarian cancer with the tumor marker CA 125].
Sevelda P; Wagner G
Wien Klin Wochenschr; 1987 Nov; 99(21):768-70. PubMed ID: 3480655
[TBL] [Abstract][Full Text] [Related]
4. [Tumor marker combination versus second-look operation in ovarian cancer].
Lahousen M; Stettner H; Pürstner P; Pickel H
Zentralbl Gynakol; 1990; 112(9):561-6. PubMed ID: 2378187
[TBL] [Abstract][Full Text] [Related]
5. [Predictive value of a tumor marker combination for the monitoring of ovarian cancer].
Lahousen M
Wien Klin Wochenschr; 1986 May; 98(10):319-25. PubMed ID: 3460273
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated antigen Ca 125 before and during the treatment of ovarian carcinoma.
Kivinen S; Kuoppala T; Leppilampi M; Vuori J; Kauppila A
Obstet Gynecol; 1986 Apr; 67(4):468-72. PubMed ID: 3008051
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers].
Sevelda P; Salzer H; Dittrich C; Spona J
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):769-73. PubMed ID: 3865860
[TBL] [Abstract][Full Text] [Related]
8. [Experiences with CA 125, a tumor marker for malignant epithelial ovarian tumors].
Crombach G; Zippel HH; Würz H
Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):205-12. PubMed ID: 2408962
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of 3 markers in ovarian cancer: CA 125, CA 19,9 and CEA].
Vigné E; Krebs B; Khater R; Mira R; Boublil JL; Jourlait A; Frenay M; Namer M
J Gynecol Obstet Biol Reprod (Paris); 1986; 15(5):609-13. PubMed ID: 3463621
[TBL] [Abstract][Full Text] [Related]
10. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemical differentiation of granulosa cell tumors and undifferentiated ovarian cancers].
Kohlberger P
Wien Klin Wochenschr; 1993; 105(20):589-90. PubMed ID: 8259687
[No Abstract] [Full Text] [Related]
12. [Possibilities and limits of the study of tumor markers in the after-care of patients with ovarian cancer].
Kreienberg R
Gynakologe; 1986 Sep; 19(3):178-85. PubMed ID: 3770529
[No Abstract] [Full Text] [Related]
13. [The value of CA 125 determination in the serum of patients with ovarian cancer].
Bartel U; Johannsen B; Elling D
Zentralbl Gynakol; 1989; 111(5):301-9. PubMed ID: 2728673
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical differentiation of granulosa cell tumors and ovarian cancers].
Gitsch G; Kohlberger P; Kölbl H; Krepler R; Breitenecker G
Gynakol Rundsch; 1991; 31 Suppl 2():370-2. PubMed ID: 1790983
[No Abstract] [Full Text] [Related]
15. Granulosa cell tumor of the ovary.
Maleemonkol S; Chareonium V; Isariyodom P; Faichamnan S
J Med Assoc Thai; 1996 Oct; 79(10):648-53. PubMed ID: 8997000
[TBL] [Abstract][Full Text] [Related]
16. [Para-aortic lymph node recurrence of struma tumors and germ cell tumors of the ovary].
Petru E; Pickel H; Lahousen M; Heydarfadai M; Auner J
Gynakol Rundsch; 1991; 31 Suppl 2():274-5. PubMed ID: 1665137
[No Abstract] [Full Text] [Related]
17. [Carcinoma of the ovary: reliability of its markers].
Moggian G; Gunelli R; Magrone F; Canali P; Spadazzi AP; Pini PL
Minerva Ginecol; 1988 Jan; 40(1):9-13. PubMed ID: 3163780
[No Abstract] [Full Text] [Related]
18. [The value of preoperative diagnosis before second-look laparotomy in ovarian cancer].
Meden H; Rath W; Ohlmeyer D
Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):101-5. PubMed ID: 2180783
[TBL] [Abstract][Full Text] [Related]
19. [Ovarian carcinoma antigen (CA 125) and ovarian cancer (clinical follow-up and prognostic studies)].
Göcze P; Vahrson H
Orv Hetil; 1993 Apr; 134(17):915-8. PubMed ID: 8479736
[TBL] [Abstract][Full Text] [Related]
20. Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer.
Scambia G; Panici PB; Baiocchi G; Perrone L; Iacobelli S; Mancuso S
Anticancer Res; 1988; 8(4):761-4. PubMed ID: 3178164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
